GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Research & Development

China National Medicines (SHSE:600511) Research & Development : ¥74 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. China National Medicines's Research & Development for the three months ended in Mar. 2025 was ¥14 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥74 Mil.


China National Medicines Research & Development Historical Data

The historical data trend for China National Medicines's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Research & Development Chart

China National Medicines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.87 55.75 67.00 71.20 73.71

China National Medicines Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.94 14.85 15.35 29.57 13.82

China National Medicines Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Medicines  (SHSE:600511) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


China National Medicines Research & Development Related Terms

Thank you for viewing the detailed overview of China National Medicines's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Medicines Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics and biochemical drugs.
Executives
Chen Zhang Qing Director

China National Medicines Headlines

No Headlines